Researchers with the FDA’s Office of Prescription Drug Promotion (OPDP) plan to continue with a study to investigate the influence of targeted mechanism of action (targeted MoA) claims, graphics and disclosures that provide context about a drug’s targeted MoA. The researchers announced the study in October 2021 and received a number of comments about the research. Building u... Read More